Biopharma Co. Advicenne Plans Cross-Listing In Brussels

By Adam Rhodes (May 24, 2019, 1:14 PM EDT) -- French pharmaceutical company Advicenne said it plans to list on the Euronext Brussels in a proposed secondary listing that would see the Paris-listed company's shares trade on the two largest Euronext markets for life sciences companies....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!